Neurones S.A. (EPA:NRO)
34.60
-1.60 (-4.42%)
At close: Mar 13, 2026
Neurones Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 326.49 | 297.76 | 272.06 | 265.17 |
Cash & Short-Term Investments | 326.49 | 297.76 | 272.06 | 265.17 |
Cash Growth | 9.65% | 9.45% | 2.60% | -0.54% |
Accounts Receivable | 214.71 | 207.67 | 192.23 | 164.64 |
Other Receivables | 28.64 | 27.64 | 32.35 | 24.6 |
Receivables | 243.36 | 235.31 | 224.58 | 189.24 |
Inventory | 0.27 | 0.71 | 0.35 | 0.89 |
Prepaid Expenses | 18 | 12.04 | 9.58 | 8.83 |
Total Current Assets | 588.11 | 545.81 | 506.57 | 464.13 |
Property, Plant & Equipment | 60.53 | 58.73 | 48.77 | 46.1 |
Long-Term Investments | 4.77 | 4.15 | 3.44 | 3.22 |
Goodwill | 56.24 | 53.23 | 45.02 | 44.41 |
Other Intangible Assets | 1.95 | 1.48 | 1.05 | 1.44 |
Long-Term Deferred Tax Assets | 6.9 | 6.1 | 5.28 | 3.45 |
Total Assets | 725.69 | 676.1 | 616.22 | 567.82 |
Accounts Payable | 58.33 | 44.04 | 42.93 | 37.73 |
Accrued Expenses | 119.23 | 116.44 | 106 | 97.37 |
Short-Term Debt | 4.92 | 5.84 | 0.15 | 0.21 |
Current Portion of Leases | 7.61 | 7.22 | 8.01 | 7.29 |
Current Income Taxes Payable | 3.58 | 3.48 | 7.99 | 5.6 |
Current Unearned Revenue | 27.43 | 24.18 | 21.43 | 19.7 |
Other Current Liabilities | 31.55 | 27.72 | 20.59 | 16.67 |
Total Current Liabilities | 252.66 | 228.92 | 207.1 | 184.56 |
Long-Term Debt | 2.05 | 1.51 | 0.11 | 0.2 |
Long-Term Leases | 27.44 | 29.42 | 27.3 | 27.62 |
Pension & Post-Retirement Benefits | 7.37 | 6.5 | 6.13 | 2.52 |
Total Liabilities | 289.52 | 266.34 | 240.64 | 214.9 |
Common Stock | 9.71 | 9.71 | 9.69 | 9.69 |
Additional Paid-In Capital | 16.28 | 31.38 | 31.4 | 31.4 |
Retained Earnings | 52.56 | 49.41 | 44.24 | 37.71 |
Treasury Stock | -0.2 | -0.45 | -0.19 | -0.26 |
Comprehensive Income & Other | 299.76 | 265.7 | 245.43 | 233.02 |
Total Common Equity | 378.1 | 355.75 | 330.58 | 311.56 |
Minority Interest | 58.07 | 54 | 45 | 41.36 |
Shareholders' Equity | 436.17 | 409.76 | 375.58 | 352.92 |
Total Liabilities & Equity | 725.69 | 676.1 | 616.22 | 567.82 |
Total Debt | 42.02 | 43.98 | 35.57 | 35.32 |
Net Cash (Debt) | 284.47 | 253.78 | 236.49 | 229.85 |
Net Cash Growth | 12.10% | 7.31% | 2.89% | -1.11% |
Net Cash Per Share | 11.68 | 10.44 | 9.74 | 9.48 |
Filing Date Shares Outstanding | 24.27 | 24.27 | 24.22 | 24.22 |
Total Common Shares Outstanding | 24.27 | 24.27 | 24.22 | 24.22 |
Working Capital | 335.46 | 316.89 | 299.47 | 279.57 |
Book Value Per Share | 15.58 | 14.66 | 13.65 | 12.86 |
Tangible Book Value | 319.91 | 301.04 | 284.51 | 265.7 |
Tangible Book Value Per Share | 13.18 | 12.40 | 11.75 | 10.97 |
Land | 0.69 | 0.1 | 0.1 | 0.1 |
Machinery | 95.9 | 88.59 | 74.49 | 66.63 |
Construction In Progress | 1.08 | 0.02 | 0.49 | 0.03 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.